Efficient Lentiviral Transduction of Human Mesenchymal Stem Cells That Preserves Proliferation and Differentiation Capabilities

Long‐term lentiviral transduction of human mesenchymal stem cells (hMSCs) greatly enhances the usefulness of these cells. However, such transduction currently requires the use of polybrene, which severely inhibits hMSC proliferation. In contrast, protamine sulfate at 100 μg/ml doubled transduction efficiencies without affecting proliferation or differentiation potential. Expression levels improved 2.2‐fold with the addition of a woodchuck hepatitis post‐transcriptional regulatory element. Further improvements in transduction efficiencies could be obtained by a modest increase in viral concentrations through increased viral titers or decreased transduction volumes without changing multiplicity of infection, by transducing over multiple days, or by culturing the cells in fibroblast growth factor‐2. Centrifugation improved expression but had no effect on efficiency. Transgene expression was stable over 6 weeks in vitro and in vivo. Donor‐to‐donor and intradonor variability were observed in primary passage through passage 2 cultures, but not at passage 3. These results provide a better optimized approach for expanded use of hMSCs through genetic manipulation.

[1]  D. Rowlands,et al.  Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury , 2012, Nature Medicine.

[2]  A. Caplan,et al.  Polybrene Inhibits Human Mesenchymal Stem Cell Proliferation during Lentiviral Transduction , 2011, PloS one.

[3]  J. Welter,et al.  Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential , 2011, Stem cells international.

[4]  J. L. Santos,et al.  Non-viral gene delivery to mesenchymal stem cells: methods, strategies and application in bone tissue engineering and regeneration. , 2011, Current gene therapy.

[5]  A. Caplan,et al.  Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[6]  V. Goldberg,et al.  Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. , 2010, Tissue engineering. Part A.

[7]  T. Lawrence,et al.  Radiation increases invasion of gene-modified mesenchymal stem cells into tumors. , 2009, International journal of radiation oncology, biology, physics.

[8]  M. Andreeff,et al.  Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging , 2009, Stem cells.

[9]  A. Arndt,et al.  Towards a Clinically Relevant Lentiviral Transduction Protocol for Primary Human CD34+ Hematopoietic Stem/Progenitor Cells , 2009, PloS one.

[10]  Sanjiv S. Gambhir,et al.  Trafficking Mesenchymal Stem Cell Engraftment and Differentiation in Tumor‐Bearing Mice by Bioluminescence Imaging , 2009, Stem cells.

[11]  Manuel A. González,et al.  Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. , 2009, Arthritis and rheumatism.

[12]  Ralph Weissleder,et al.  Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.

[13]  C. Svendsen,et al.  Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  H. Friess,et al.  Improved lentiviral transduction of human mesenchymal stem cells for therapeutic intervention in pancreatic cancer , 2008, Cancer Gene Therapy.

[15]  Sanjay Kumar,et al.  Bone homing of mesenchymal stem cells by ectopic α4 integrin expression , 2007 .

[16]  Z. Popović,et al.  SDF‐1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  P. Malik,et al.  The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors , 2007, Gene Therapy.

[18]  Daniel A. Grande,et al.  Mesenchymal Stem Cells in Tissue Engineering , 2006, Cells Tissues Organs.

[19]  H. Vandenburgh,et al.  Efficient Lentiviral Transduction and Improved Engraftment of Human Bone Marrow Mesenchymal Cells , 2006, Stem cells.

[20]  A. Arbab,et al.  Labeling of cells with ferumoxides–protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells , 2005, NMR in biomedicine.

[21]  Xian-Yang Zhang,et al.  Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases , 2005, Expert opinion on biological therapy.

[22]  R. Tuan,et al.  Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro , 2005, Molecular biotechnology.

[23]  M. Andreeff,et al.  Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. , 2005, Cancer research.

[24]  Moustapha Hassan,et al.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.

[25]  B. Larson,et al.  Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. , 2004, Blood.

[26]  R. Tsien,et al.  Imaging Tri-Fusion Multimodality Reporter Gene Expression in Living Subjects , 2004, Cancer Research.

[27]  J. Ingwall,et al.  Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts , 2003, Nature Medicine.

[28]  F. Kloss,et al.  Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes , 2003, Gene Therapy.

[29]  M. Andreeff,et al.  Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.

[30]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[31]  Ya-Wun Yang,et al.  Protamine Sulfate Enhances the Transduction Efficiency of Recombinant Adeno-Associated Virus-Mediated Gene Delivery , 2001, Pharmaceutical Research.

[32]  M. Chopp,et al.  Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats , 2001, Stroke.

[33]  M. Malim,et al.  Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding , 2000, Journal of Virology.

[34]  T. VandenDriessche,et al.  Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice. , 2000, Human gene therapy.

[35]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[36]  T. Hope,et al.  Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors , 1999, Journal of Virology.

[37]  A. Caplan,et al.  In vivo osteogenesis assay: a rapid method for quantitative analysis. , 1998, Biomaterials.

[38]  J. Allay,et al.  LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. , 1997, Human gene therapy.

[39]  S. Kadiyala,et al.  Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect , 1997 .

[40]  Scott P. Bruder,et al.  Human and animal mesenchymal progenitor cells from bone marrow: Identification of serum for optimal selection and proliferation , 1996, In Vitro Cellular & Developmental Biology - Animal.

[41]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[42]  A I Caplan,et al.  Cytokine expression by human marrow‐derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL‐1α , 1996, Journal of cellular physiology.

[43]  M. Emerman,et al.  Human immunodeficiency virus infection of cells arrested in the cell cycle. , 1992, The EMBO journal.

[44]  Arnold I. Caplan,et al.  Mesenchymal Stem Cells , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[45]  K. Cornetta,et al.  Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy. , 1989, Journal of virological methods.

[46]  J. Welter,et al.  Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks. , 2011, Methods in molecular biology.

[47]  S. Miller,et al.  Human bone marrow‐derived mesenchymal stem cells induce Th2‐polarized immune response and promote endogenous repair in animal models of multiple sclerosis , 2009, Glia.

[48]  Sanjay Kumar,et al.  Bone homing of mesenchymal stem cells by ectopic alpha 4 integrin expression. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  A. Caplan Osteogenesis imperfecta, rehabilitation medicine, fundamental research and mesenchymal stem cells. , 1995, Connective tissue research.

[50]  A I Caplan,et al.  Characterization of cells with osteogenic potential from human marrow. , 1992, Bone.

[51]  P. Esposito,et al.  Osteogenesis Imperfecta. , 1928, Proceedings of the Royal Society of Medicine.